Abstract
Background
Numerous adverse immune reactions after hyaluronan (HA) applications have been reported, highlighting the need for investigating the differences in metabolism and pharmacokinetics between homeostasis and tissue injury and inflammation conditions. Understanding the mechanisms underlying the pro- or anti-inflammatory activity of HA depending on its fragment size and the association between HA fragment size and its pharmacokinetics and therapeutic properties is critical to its use without adverse immune reactions.
Area covered
This paper discusses the differential synthesis and degradation of HA depending on physiological conditions and HA fragment size and the strategies to minimizing adverse immune reactions. Given HA is an important skin component, its skin penetration, dermal pharmacokinetics and differential effects of native HA and fragments on wound healing and tissue regeneration are discussed.
Expert opinion
In ideal homeostatic conditions, the proportion of high-molecular-weight HA (HMW HA; ~106 Da, 1.24 M Da) is high, and it rarely binds with immune cells. However, tissue injury and inflammation lead to the generation of small HA fragments (~ 100 kDa and 10 kDa), which exhibit inflammatory, carcinogenic, and tissue fibrotic properties. As HA is an indispensable extracellular matrix (ECM) component of skin, specific skin absorption enhancement induced by conversion of the α-helix to a ß-sheet structure of HA and hydration of stratum corneum weakens the SC barrier. Given different cell types react differently to cellular stresses. Currently, no general guideline to prognosticating serious adverse reactions after HA application exists. Therefore, we believe that normalization of HA metabolism and an in vitro model evaluating the specific inflammatory cytokine profile and gene expression level in macrophage cell lines of tested tissue after HA exposure would help in devising a clinical strategy to minimize the serious adverse reactions after HA application.
Similar content being viewed by others
References
Abe Y, Seino S, Kurihara H, Madoka K, Tokudome Y (2022) 2- kDa hyaluronan ameliorates human facial wrinkles through increased dermal collagen density related to promotion of collagen remodeling. J Cosmet Dermatol. org/10.111/jocd.15097
Alijotas-Reig J, Garcia-Gimenez V (2008) Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel der-mal fillers: clinical findings, long-term follow up and review of the literature. J Eur Acad Dermatol Venereol 22:150–161
Al-Shraim M, Jaragh M, Geddie W (2007) Granulomatous reaction to injectable hyluronic acid (restylane) diagnosed by fine needle biopsy. J Clin Pathol 60:1060–1061
Anduljabbar MH, Basendwh M (2016) Complications of hyaluronic acid fillers and their managements. J Dermatology & Dermatologic Surgery 20:100–106
Argen UN, Tammi M, Tammi R (1995) Hydrocortisone regulation of hyaluronan metabolism in human skin organ culture. J Cell Physiol 164:240–248
Argen UM, Tammi M, Ryynanen M et al (1997) Developmentally programmed expression of hyaluronan in human skin and its appendages. J Invest Dermatol 109:219–224
Aya KL, Stern R (2014) Hyaluronan in wound healing: rediscovering a major player. Wound Rep Reg 22:579–593
Balaji S, Wang X, King A, Louis D, Le, Bhattachara SS et al (2017) Interleukin-10 mediated regenerative postnatal tissue repair is dependent on regulation of hyaluronan metabolism via fibroblast-specific STAT3 signaling. FASEB J 31:868881
Balazs, Endre A (1979) Ultrapure Hyaluronic Acid and the Use Thereof U.S. Patent 4,141,973
Barry BW (1987) Mode of action of penetration enhances in human skin. J control Rel 6:85–97
Beleznay K, Carruthers JD, Carruthers A, Mummert ME, Humphrey S (2015) Delayed-onset nodules secondary to a smooth cohesive 20 mg/mL hyaluronic acid filler: cause and management. Dermatol Surg 41(8):929–939
Bernard G, Auger M, Soucy J, Pouiot R (2007) Physical characterization of the stratum corneum of an in vitro psoriatric skin model by ATR-FTIR and raman spectroscopies. Biochim Biophys Acta 1770:1317–1323
Bitterman-Deutsch O, Kogan L, Nasser F (2015) Delayed immune mediated adverse effects to hyaluronic acid fillers: report to five cases and review of the literature. Dermatology Rep 7(1):5851
Boas NF (1949) Isolation of hyaluronic acid from the cock’s comb. J Biol Chem 181:573–575
Brown MB, Jones SA (2005) Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin. Eur Acad Dermatology Venereol JEADV 19:308–318
Brown TJ, Alcorn D, Fraser JRE (1999) Absorption of hyaluronan applied to the surface of intact skin. J Invest dermatology 113(5):740–746
Bukhari SNA, Roswandi NL, Waqas M et al (2018) Hyaluronic acid, a promising skin rejuvenating biomedicine: a review of recent updates and pre-clinical and clinical investigations on cosmetic and nutricosmetic effects. Int J Biol Macromol 120(120):1682–1695
Cavallinin M, Gazzola R, Metalla M, Valenti L (2013) The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers. Am Soc Aesthetic Plast Surg AICPE 33(8):1167–1174
Chen WYJ, Giovanni A (1999) Functions of hyaluronan in wound repair.7:79–88
Cho Lee AR (2019) Microneedle-mediated delivery of cosmeceutically relevant nucleoside and peptides in human skin: challenges and strategies for dermal delivery. J Pharm Invest 49:587–601
Choi JT, Park SJ, Park JH (2018) Microneedles containing cross-linked hyaluronic acid particulates for control of degradation and swelling behaviour after administration into skin. J Drug Target. https://doi.org/10.1080/1061186X.2018.1435664
Christensen L, Breitning V, Jannssen M, Vuust J, Hogdall E (2005) Adverse reactions to injectable soft tissue permanent fillers. Aesth Plast Surg 29:34–48
Cilurlzo F, Vistoli G, Gennari CGM, Selmin F et al (2014) The role of conformational profile of polysaccharide on skin penetration: the case of hyaluronan and its sulfates. Chem & Biodiversity 11:551–561
Collins SL, Black KE, Chan-Li Y, Ahn YH, Cole P et al (2011) Hyaluronan fragments promote inflammation by down-regulating the anti-inflammatory A2a receptor. Am J Respir Cell Mol Biol 45:675–683
Csoka B, Frost GI, Stern R (2001) The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol 20:499–508
Cyphert JM, Trempus CS, Garantziotis S (2015) Size matters: molecular weight specificity of hyaluronan effects in cell biology. Int J Cell Biol 563818. https://doi.org/10.1155/2015/563818
Dahl LB, kimpton WG, Cahill RN, Brown TJ, Fraser RE (1989) The origin and fate of hyaluronan in amniotic fluid. J Dev Physiol 12:209–218
Dahl LB, Dahl IMS, Engstrom-Laurent A, Granath K (2015) Concentration and molecular weight sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 44:817–822
David-Raoudi M, Tranchepain F, Deschrevel B, Vincent J, Bogdanowicz P et al (2008) Differential effects of hyaluronan and its fragments on fibroblast: relation to wound healing. Wound Rep Regen 16:274–287
De Jong WH, Jennen D, Keizers P, Hodemaekers H, Vermeulin J et al (2022) Evaluation of adverse effects of resorbable hyaluronic acid fillers: determination on macrophage responses. Int J Mol Sci 23:7275–7292. https://doi.org/10.3390/ijms23137275
Dipiro JT, Spruill WJ, Wade WE, Bloulin R, Pruemer J (1996) Concepts in clinical pharmacokinetics. Am Soc of Health Systems Pharmacists, pp 24–25
Doherty MM, Hughe PJ, Korszniak NV, Charman WN (1995) Prolonger of lidocaine –induced epidural anesthesia by medium molecular weight hyaluronic acid formulations: pharmacodynmics and pharmacokinetic studies in the rabbit. Anesth Analg 80:740–746
Donelan W, Dominguez-Gutierrez PR, Kusmartsev S (2022) Deregulated hyaluronan metabolism in the tumor microenvironment drives cancer inflammation and tumor associated immune suppression. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2022.971278
Engstrom-Laurent A, Laurent UBG, Lilja K, Laurent TC (1985) Concentration of sodium hyaluronate in serum, scand. J Clin Lab Invest 45:497–504
Erickson M, Stern R (2012) Chain gangs: New aspects of hyaluronan metabolism. Biochem 893947
Essendoubi M, Gobinet C, Reynaud R, Angiboust JF, Manfait M, Piot O (2016) Human skin penetration of hyaluronic acid of different molecular weights as probed by Raman spectroscopy. Skin Res and Tech 22:55–62
Evarard C, Lambert de Rouvroit C, Poumay Y (2021) Epidermal hyaluronan in barrier alteration-related disease. Cells 10:3096. https://doi.org/10.3390/cells10113096
Fallacara A, Baldini E, manfredini, Vertuani S (2018) Hyaluronic acid in the third millennium. Polymers (Basel) 10(7):701. https://doi.org/10.3390/polym10070701
Fraser JRE, Laurent TC, Pertoft H, Baxter E (1981) Plasma clearance, tissue distribution and meta bolism of hyaluronic acid injected intravenously in the rabbit. Biochem J 200:415–424
Fraser JR, Laurent TC, Laurent UB (1997) Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 242:27–33
Ghatak S, Misra S, Toole BP (2002) Hyaluronan oligosaccharides inhibit anchorage0independent growth of tumor cells by suppressing the phosphoinositude 3-kinase/Akt cell survival pathway. J Biol Chem 277:38013–38020
Ghosh P (1994) The role of hyaluronic acid (hyaluronan) in health and disease: interactions with cells, cartilage and components of synovial fluid. Clin Exp Rheumatol 12(1):75–82
Girish KS, Kemparaju K (2007) The magic glue hyaluronan and its eraser hyaluronidase: a biological overview. Life Sci 80:1921–1943
Govindaraju P, Todd L, Shetye S, Monslow J, Pure E (2019) CD-44-dependent inflammation, fibrogenesis, and collagenolysis regulates extracellular matrix remodeling and tensile strength during cutaneous wound healing. Matrix Biol 75–76:314–330. https://doi.org/10.1016/j.matbio.2018.06.004
Hascall VC, Laurent TC (1997) Hyaluronan: structure and physical properties. Glycoforum: Science of Hyaluronan Today. Available from: http://www.glycoforum.gr.jp/science/hyaluronan/HA01/HA01E.htm
Hertel W, Peschel G, Ozegowski JH, Muller PJ (2006) Inhibitory effects of triterpenes and flavonoids on the enzymatic activity of hyaluronic acid. Archives of Pharmaceutical Chemistry and Life Sciences 339:313–318
Holmes MWA, Bayliss MT, Muir H (1988) Hyaluronic acid in human articular cartilage. Age-related changes in content and size. Biochem J 250:435–441
Homsy A, Ruegg EM, Jandus P, Pittet-Cuenod B, Modarressi A (2017) Immunological reaction after facial hyaluronic acid injection. Case Rep Plast Surg Hand Surg 4(1):68–72
Iocono JA, Colleran KR, Remick DG, Gillespie BW, Ehrlich HP et al (2000) Interleukin-8 levels and activity in delayed-healing human thermal wounds. Wound Repair Regen. https://doi.org/10.1046/j.1524-475x.2000.00216.x
Jang MJ, Bae SK, Jung YS, Kim JC, Park ST et al (2021) Enhanced wound healing using a 3D printed VEGF-mimicking peptide incorporated hydrogel patch in a pig model. Biomed Mater 16:045013. https://doi.org/10.1088/1748-605X/abf1a8
Jardin L, Louis H, Frost GI (2012) A comprehensive model of hyaluronan turnover in the mouse. Matrix Biol 31:81–89
Jiang D, Liang J, Fan J, Yu S, Chen S et al (2005) Regulation of lung injury and repair by toll-like receptors and hyaluronan. Nat Med 11:1173–1179
Johnson P, Arif AA, Lee -Sayer SM, Dong Y (2018) Hyaluronan and its interactions with immune cells in the healthy and inflamed lung. Frontiers in Immmunology 9: article 2787. https://doi.org/10.3389/fimmu.2018.02787
Jo IH, Bhang SH (2022) Nano-sized materials for tissue regeneration. Tissue Eng Regen Med 19:203–204
Jordan Ar, Racine RR, Henning MJ, Lokeshwar VB (2015) The role of CD 44 in disease pathology and targeted treatment. Front Immunol 6:182
Jung JH, Jin SG (2021) Microneedle for transdermal drug delivery: current trends and fabrication. J Pharm Invest 51:503–517
Kablik J, Monhett GD, Yu L, Chang G, Gershkovich J (2009) Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg 35:302–312
Kakegawa H, Mitsuo N, Matsumoto H, Satoh T, Akagi M et al (1985) Hyaluronidase-inhibitory and anti-allergic activities of the photoirradiated products of tranilast. Chem Pharm Bull 33:3738–3744
Kakegawa H, Matsumoto H, Satoh T (1988) Inhibitory effects of hydrangenol derivatives on the activation of hyaluronidase and their antiallergic activities. Planta Med 54:385–389
Kaul A, Short WD, Wang X, Keswani SG (2021) Hyaluronidases in human diseases. Int J Mol Sci 22:3204. https://doi.org/10.3390/ijms22063204
Kavasi R-M, Berdiaki A, Spyridaki I, Corsini E, Tsatsakis A et al (2017) HA metabolism in skin homeostasis and inflammatory disease. 101:128–138
Kendall FE, Heidelberger M, Dawson MH (1937) A serologically inactive polysaccharide elaborated by mucoid strains of group a hemolytic streptococcus. J Biol Chem 118:61–69
Kim Y, Lee YS, Hahn JH, Choe J, Kwon HJ et al (2008) Hyaluronic acid targets CD44 and inhibits FcepsilonRI signaling involving PKCdelta, Rac1, ROS, and MAPK to exert anti-allergic effect. Mol Immunol 45(9):2537–2547
Kimura M, Maeshima T, Kubota T, Kurihara H, Masuda Y et al (2016) Absorption of orally administered Hyaluronan. J Med food 19(12):1172–1179
Klein AW (2004) Granulomatous foreign body reaction against hyaluronic acid. Dermtol Surg 30:1070
Kobayashi Y, Okamoto A, Nishinari K (1994) Viscoelasticity of hyaluronic acid with different molecular weights. Biorheology 31:235–244
Lafaille P, Benedetto A (2010) Fillers: contraindications, side effects and precautions. Cutan Aesthet Surg 3(1):16–19
Laurent TC, Fraser JR (1986) The properties and turnover of hyaluronan. Ciba Found Symp. 124:9–29
Laurent CT, Fraser JR (1992) Hyaluronan FASEB J 6:2397–2404
Laurent UBG, Tengblad A (1980) Determination of hyaluronate in biological samples by a specific radioassay technique. Anal Biochem 109:386–394
Laurent TC, Laurent UB, Fraser JR (1996) Serum hyaluronan as a disease marker. Ann Med 28:241–253
Lebel L (1991) Clearance of hylauronan from the circulation. Adv Drug Deliv Rev 7(2):221–235
Lee AR, Tojo K (eds) (2001) An experimental approach to study the binding properties of vitamin E (alpha-tocopherol) during hairless mouse skin permeation. Chem Pharm Bull 49(6):659 – 63. https://doi.org/10.1248/cpb.49.659
Lee BM, Park SJ, Noh I, Kim CH (2021) The effects of the molecular weights of hyaluronic acid on the immune responses. Biomaterials Res. https://doi.org/10.1186/s40824-021-00228-4
Lee-Sayer SS, Dong Y, Arif AA, Olsson M, Brown KL, Johnson P (2015) The where, when, how, and why of hyaluronan binding by immune cells. Front Immunol 6:150
Lepperdinger G, Mullegger J, Kreil G (2001) Hyal2—Less active, but more versatile? Matrix Biol 20:509–514
Leung A, Crombleholme TM, Keswani SG (2012) Fetal wound healing: implications for minimal scar formation. Curr Opin Pediatr 24:371–378. https://doi.org/10.1097/MOP.0b013e3283535790
Litwiniuk M, Krejner A, Speyrer MS, Gauto AR, Grzela T (2016) Hyaluronic acid in inflammation and tissue regeneration. Wounds 28(3):78–88
Lokeshwar VB, Selzer MG (2000) Differences in Hyaluronic Acid-mediated functions and signaling in arterial, Microvessel, and vein-derived human endothelial cells. J Biol Chem 275:27641–27649
Martin E (2016) Hyaluronan: more than just a wrinkle filler. Glycobiology 26(6):553–559
Massone C, Horn M, Kerl H et al (2009) Foreign body granuloma due to Matridex injection for cosmetic purposes. Am J Dermatopathol 31:197–199
Mckee C, Penno M, Cowman M, et al (1996) Noble P. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages: the role of HA size and CD 44. J Clin Invest98:2403–2413
Meyer L, Palmer J (1934) The polysaccharide of the vitreous humour. Biol Chem 107:629–634
Mio K, Stern R (2002) Inhibitors of the hyaluronidases. Matrix Biol 21:31–37
Mummert ME (2005) Immunologic roles of hyaluronan. Immuno Res 31(3):189–205
Neuman MG, Cohen LB, Nanau RM (2016) Hyaluronic acid as a non-invasive biomarker of liver fibrosis. Clin Biochem 49:302–315
Noble PW (2002) Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 21:25–29
Noh I, Lee K, Rhee YS (2022) Microneedle systems for delivering nucleic acid drugs. J Pharm Invest 52:273–292
Owczarczyk-Saczonek A, Zdanowska N, Wygonowska E, Placek W (2021) The immunogenicity of hyaluronic fillers and its consequences. Clin Cosmet Invest Dermatology 14:921–934
Pandey MS, Harris EN, Weigel JA, Weigel PH (2008) The cytoplasmic domain of the hyaluronan receptor for endocytosis (HARE) contains multiple endocytic motifs targeting coated pit-mediated internalization. J Biol Chem 283(31):21453–21461
Papalonstantinou E, Roth M, Kakariulakis G (2012) Hyaluronic acid: a key molecule in skin aging. 4:253–2583
Papakanstantinou E, Bonovolias I, Roth M, Tamm m, Schumann D et al (2019) Serum levels of hyaluronic acid are associated with COPD severity and predict survival. Eur respiratory J. https://doi.org/10.1183/13993003.01183-2018
Park S, Lim LT (2014) Orbital inflammation secondary to delayed hypersensitivity reaction to Sub-Tenon’s hyaluronidase. Sem in Ophthalmology 29(2):57–58
Petrey AC, de la Motte CA (2014) Hyaluronan, a crucial regulator of inflammation. Frontiers in immunology. https://doi.org/10.3389/fimmu.2014.00101
Philipp-Dormston WG, Hilton S, Nathan M (2014) A prospective, open-label, multicenter, observational, postmarket study of the use of a 15 mg/ml hyaluronic acid dermal filler in the lips. J Cosmet Dermatol 13(2):125–134
Poole AR, Witter J, Roberts N, Piccolo F, Brandt R, Paquin J, Baron M (1990) Inflammation and cartilage metabolism in rheumatoid arthritis: studies of the blood markers hyaluronc acid, orosomucoid amd keratin sulfate. Arthritis Rheum 33:790–799
Rayahin JE, Buhrman JS, Zhang Y, Koh TJ, Gemeinhart RA (2015) High and low molecular weight hyaluronic acid differentially influence macrophage activation. ACS Biomater Sci Eng 1(7):481–493
Reed RK, Lilja K, Laurent TC (1988) Hyaluronan in the rat with special reference to the skin. Acta Physiol Scand 134:405–411
Robert L, Robert AM, Renard G (2010) Biological effects of hyaluronan in connective tissues, eye, skin, venous wall. Role in aging Pathologie Biologie 58(3):187–198
Romagnoli M, Belmontesi M (2008) Hyaluronic acid based fillers: theory and practice. Clin Dermatol 26:123–159
Romo M, Lopez-Vicario C, Perez-Romero N, Casulleras M, Isabel A et al (2022) Small fragments of hyaluronan are increased in individuals with obesity and contribute to low-grade inflammation through TLR-mediated activation of innate immune cells. Intl J obesity 45:1969–1969
Ronny R, Mark ME, Hyaluronan Endocytosis (2012) : Mechanisms of Uptake and Biological Functions. In MolecularRegulation of Endocytosis; Chap. 14; Ceresa, B., Ed.; IntechOpen: London, UK,
Rooney P, Kumar S, Ponting J, Wang M (1995) The role of hyaluronan in tumour neovascularization (review). Int J Cancer 60(5):632–636
Rowley JE, Amargant F, Zhou LT, Galligos A, Simon LE et al (2020) Low molecular weight hyaluronan induces an inflammatory response in ovarian stromal cells and impairs gamete development in vitro. Int J Mol Sci 21(3):1036
Ruppert SM, Hawn TR, Arrigoni A, Wight TN, Bollyky PL (2014) Tissue integrity signals communicated by high-molecular weight hyaluronan and the resolution of inflammation. Immunol Res 58(2–3):186–192
Rwei SP, Chen SW, Mao CF, Fang HW (2008) Viscoelasticity and wearability of hyaluronate solutions. Biochem Eng J 40:211–217
Sadeghpour M, Quatrano NA, BOTANI LM et al (2019) Delayed-onset nodules to differentially crosslinked hyaluronic acids: comparative incidence and risk assessment. Dermatol Surg 45(80):1085–1094
Shigefuji M, Tokudome Y (2020) Nanoparticulate of hyaluronic acid: a new skin penetration enhancing polyion complex formulation:mechanism and future potential. Materialia. https://doi.org/10.1016/j.mtla.2020.100879
Sidgwick GP, Iqbal SA, Bayat A (2013) Altered expression of hyaluronan synthase and hyaluronidase mRNA may affect hyaluronic acid distribution in keloid disease compared with normal skin. Exp Derm 22:377–379
Singampalli KL, Balaji S, Wang X, Parikh UM, Kaul A et al (2020) The role of an IL-10/hyaluronan axis in dermal wound healing, frontiers in cell and developmental biology. 8: article 636. https://doi.org/10.3389/fcell.2020.00636
Stair-Nawy S, Csoka AB, Stern R (1999) Hyaluronidase expression in human skin fibroblasts. Biochem Biophys Res Commun 266:268–273
Österlin S (1977) On the molecular biology of the vitreous in the aphakic eye Acta Ophthalmol (1977) 55:353–61
Stern R (2004) Hyaluronan catabolism: a new metabolic pathway. Eur J Cell Biol 83(7):317–325
Stern R (2008) Hyaluronidases in cancer biology. Seminars in Cancer Biol 18:275–280
Stern R (2014) Hyaluronan catabolism: a new metabolic pathway. Eur J Cell Biol 83(7):317–325
Stern R, Jedrzejas M (2006) Hyaluronidases: their genomics, structures, and mechanisms of action. Chem rev 106:818–839
Stern R, Asari AA, Sugahara KN (2006) Hyaluronan fragments: an information-rich system. Eur J Cell Biol 85(8):699–715
Sugahara KN, Murai t, Kawashima N, Saya H H et al (2003) Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J Biol Chem 278(34):32259–32265
Sundaram H, Voigts B, Beer K, Meland M (2010) Comparison of the rheological properties of viscosity and elasticity in two categories of soft-tissue fillers: calcium hydroxylapatite and hyaluronic acid. Dermatol Surg 36:1859–1866
Tammi R, Tammi M (1998) Hyaluronan in the epidermis. Glyco forum 2:A41–A15
Tammi R, Ripellino JA, Margolis RU, Maibach HI, Tammi M (1989) Hyaluronate accumulation in human epidermis treated with retinoic acid in skin organ culture. J Invest Dermatol 92:326–332
Tammi R, Säämänen AM, Maibach HI, Tammi M (1991) Degradation of newly synthesized high molecular mass hyaluronan in the epidermal and dermal compartments of human skin in organ culture. J Invest dermatology 97(1):126–130
Tammi R, Ågren UM, Tuhkanen A-L, Tammi M (1994) Hyaluronan metabolism in skin. Prog Histochem Cytochem 29:1–81
Tavianatou AG, Caon I, Franchi M, Piperigkou Z, Galesso D, Karamanos NK (2019) Hyaluronan: molecular size-dependent signaling and biological functions in inflammation and cancer. FEBS 286(15):2883–2908
Tengblad A, Laurent UBG, Lilja K, Cahill RNP, Engström-Laurent A, Fraser JRE et al (1986) Concentration and relative molecular mass of hyaluronate in lymph and blood. Biochem J 236:521–525
Tobiishi M, Sayo T, Yoshida H, Kusaka A, Kawabata K et al (2011) Changes in epidermal hyaluronan metabolism following UVB irradiation. J Dermatol Sci. https://doi.org/10.1016/j.jdermsci.2011.06.006
Tokudome Y, Komi T, Omara A, Sekita M (2018) A new strategy for the passive skin delivery of nanoparticulate, high molecular weight hyaluronic acid prepared by a polyion complex method. Sci Rep 8:2336
Unn AL, Heavner JE, Racz G et al (2010) Hyaluronidase: a review of approved formulations, indications and off-label use in chronic pain management. Expert Opin Biol Ther 10:127–131
van Zuijlen PPM, Ruurda JJB, van Veen HA, van Marle J, van Trier AJM et al (2003) Collagen morphology in human skin and scar tissue: no adaptations in response to mechanical loading at joints. Burns 29:423–431. https://doi.org/10.1016/s0305-4179(03)00052-4
Vuorio E, Einola S, Hakkarainen S, Penttinen R (1982) Synthesis of underpolymerized hyaluronic acid by fibroblasts cultured from rheumatoid and non-rheumatoid synovitis. Rheumatol Int 2(3):97–102
Wang J, Hori K, Ding J, Huang Y, Kwan P et al (2011) Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring. J Cell Physiol 226:1265–1273. https://doi.org/10.1002/jcp.22454
Weindl G, Schaller M, Schafer-Korting M, Korting HC (2004) Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects. Skin Pharmacol Physiol 17:207–213
West DC, Hampson IN, Arnold F, Kumar S (1985) Angiogenesis induced by degradation products of hyaluronic acid. Science 228(4705):1324–1326
Witting M, Boreham A, Brodwolf R, Vavrova K, Alexiev U, Friess W, Hedtrich S (2015) Interactions of hyaluronic acid with the skin and implications for the dermal delivery of biomolecules. Mol Pharm 12:1391–1401
Xu H, Ito T, Tawada A, Maeda H, Yamanokuchi H et al (2002) Effect of hyaluronan oligosaccharides on the expression of heat shock protein. J Biol Chem 277:17308–17314
Yoshida M, Sai S, Marumo K, Tanaka T, Itano N et al (2004) Expression analysis of three isoforms of hyaluronan synthase and hyaluronidase in the synovium of knees in osteoarthritis and rheumatoid arthritis by quantitative real-time reverse transcriptase polymerase chain reaction. Arthritis Res Ther 6(6):R514–R520
Yoshida H, Nagaoka A, Kusaka-Kikushima A, Tobiishi VM, Kawabata K et al (2013) KIAA1199, a deafness gene of unknown function, is a new hyaluronan binding protein involved in hyaluronan depolymerization. Proc Natl Acad Sci USA 110:5612–5617
Yoshida H, Yamazaki K, Komiya A, Aoki M, Nakamura T et al (2019) Inhibition of HYBID (KIAA1199)-mediated hyaluronan degradation and anti-wrinkle effect of Geranium thunbergii extract. J Cosmet Dermatol 18(4):1052–1060
Yoshida H, Aoki M, Komiya A, Endo Y, Kawabata K et al (2020) HYBID (alias KIAA1199/CEMIP) and hyaluronan synthase coordinately regulate hyaluronan metabolism in histamine-stimulated skin fibroblasts. J Biol Chem 295:2483–2494. https://doi.org/10.1074/jbc.RA119.010457
Zadnikova P, Sinova R, Pavlik V, Simek M, Safrankova B et al (2022) The degradation of hyaluronan in the skin. Biomolecules 12:251–268
Zielke H, Wolber L, Wiest L, Rzany B (2008) Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study). Dermatol Surg 34(3):326–335
Acknowledgements
This work was supported in part by the Duksung Women’s University research Grants 2020.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author (Ae-Ri Cho Lee) declares that there is no conflict of interest.
Statement of human and animal rights
This article does not contain any studies with human and animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cho Lee, AR. Size matters: differential property of hyaluronan and its fragments in the skin- relation to pharmacokinetics, immune activity and wound healing. J. Pharm. Investig. 53, 357–376 (2023). https://doi.org/10.1007/s40005-023-00614-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40005-023-00614-1